Statins and risk of breast cancer recurrence

BACKGROUND: The primary end point of our study was to test whether the concurrent use of a statin is related to a lower risk of recurrence and increased relapse-free survival in patients with early breast cancer. MATERIALS AND METHODS: We reviewed 610 female patients with stage I, II, or III breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakellakis, Minas, Akinosoglou, Karolina, Kostaki, Anastasia, Spyropoulou, Despina, Koutras, Angelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104306/
https://www.ncbi.nlm.nih.gov/pubmed/27853392
http://dx.doi.org/10.2147/BCTT.S116694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104306/
https://www.ncbi.nlm.nih.gov/pubmed/27853392
http://dx.doi.org/10.2147/BCTT.S116694

Ejemplares similares